Chile Registration Holder Requirements: The Titular and Local Entity Rule
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
A foreign manufacturer cannot directly hold a Chilean sanitary registration in its own name. The registration must be filed by a natural person or legal entity legally established in Chile — the titular (registration holder), also known in practice as the authorized representative (representante autorizado) — and the certificate is held in that entity’s name. The hard technical threshold is that the ISP submission system GICONA identifies applicants by their Chilean tax number (RUT); without a Chilean tax number and a prior company registration, the submission procedure cannot even be opened.
GRZAN stresses a second layer of meaning: the registration holder is not a name on paper but the responsible entity. Technical vigilance reporting, recalls, change notifications and renewal obligations all fall on the local entity. Who occupies this position is a matter that must be settled in the first round of commercial negotiation, not discovered during submission preparation when the structure is already locked in by the distribution arrangement. Once a certificate has been granted in a distributor’s name, changing the holder means a new application cycle, and the negotiating position of the manufacturer weakens with every month the product spends in the channel under that name.
2. Legal basis
- Regulation on the control of medical products and devices | Decreto Supremo N° 825, de 1998 | 21 August 1999 | Article 3: any person intending to manufacture, import, sell or distribute controlled devices must first obtain a conformity verification certificate.
- Sanitary Code | DFL N° 725, de 1967 | Article 111, subparagraph a) | control and certification must be performed by ISP-authorized institutions (with a Chilean entity as the application and responsibility node).
- Same instrument | Article 111, subparagraph g) | the use and disposal of devices require ISP authorization (directed at the holder and importer entities).
- ISP procedure | prestación 9100003 (version v3, 25 September 2025) | sanitary registration submission procedure; submissions are made through the GICONA platform and require a Chilean tax number and prior company registration.
- ISP technical guidance | ANDID/024 | defines the authorized representative or registration holder as a natural person or company established in Chile that accepts written delegation from the foreign manufacturer and holds the sanitary registration of the device in its own name.
3. Expert insights
Insight 1: the threshold is not that an agent must be hired — it is that a legal entity must exist in Chile.
The difference is substantial. Chilean law does not require that the certificate be held by a commercial distributor; it only requires that the holder be established in Chile. A manufacturer may incorporate a Chilean subsidiary and hold the registration itself, or delegate to a third party. The choice belongs to the manufacturer, and so does the risk. Treating the local holder requirement as a forced sale of your registration to your distributor is a misreading of the rule with long-term commercial consequences. The realistic comparison is between the cost of maintaining your own local entity and the strategic cost of a certificate that lives in someone else’s name — and for any meaningful portfolio, the first cost is the smaller one.
Insight 2: the holder carries continuing obligations, not a one-time signature.
Technical vigilance reporting, recall execution, change notifications, renewal and cooperation with inspections all rest on the registration holder. Article 28 of DS 825/1998 and the subsequent technical vigilance rules direct the reporting obligations at importers and holders. If the holder does not cooperate, the manufacturer cannot fulfill those obligations alone — this is the most common loss of control after a certificate has been handed to a distributor. Assess the holder’s regulatory capability, not only its commercial reach.
Insight 3: combining the holder and importer roles is the most cost-efficient structure.
Every importation of controlled devices requires a CDA (customs clearance certificate) and an authorization for use and disposal, and both point to the holder and importer entity. A separated structure creates breakpoints in the authorization chain: goods arrive at port, but the use and disposal authorization sits in another entity’s name. Every such breakpoint means customs delays, duplicated fees and negotiation between two companies over documents that should move automatically. For cold-chain and time-sensitive products, a customs delay is not merely an administrative cost — it can consume shelf life and trigger quality investigations on arrival.
Insight 4: control is secured by contract, not by trust.
GRZAN requires three types of clauses in every Chilean project: transfer-upon-demand of the registration, handover after termination, and ownership of technical files and cooperation obligations. One commercial principle should also be written down explicitly: whoever pays controls — never let the distributor fund the application, because a certificate paid for by the distributor will inevitably be used as a negotiating chip in later price and exclusivity discussions.
4. Practical recommendations
- Settle the holder structure in the first round of commercial negotiation, not in the week before submission.
- Prefer a combined holder-plus-importer structure or a holder-plus-exclusive-importer binding structure to avoid breakpoints in the authorization chain.
- Write transfer-upon-demand, termination handover and technical file ownership clauses into the distribution agreement, and have local Chilean counsel confirm their enforceability.
- Have the manufacturer fund the application: the paying party decides who controls the certificate, and this must be stated in the agreement.
- Assign a technical vigilance officer and a deputy for the holder, and fix information-sharing deadlines in the agreement.
5. Verification checklist
- □ It has been confirmed that a foreign entity cannot directly hold the certificate and that a Chilean holder must be incorporated or designated
- □ The holding entity has been confirmed to have a Chilean tax number (RUT) and prior company registration
- □ The structure of holder and importer has been decided (combined or bound)
- □ Transfer-upon-demand, termination handover and technical file ownership clauses have been written into the agreement
- □ The application costs have been confirmed as borne by the manufacturer
Regulatory information verified as of 29 October 2026.
GRZAN supports manufacturers entering the Chilean market with ISP registration pathways and classification strategy, including holder structure design and holder-agreement drafting. For a feasibility assessment of your specific product, contact the GRZAN regulatory team at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us